-
Broader markets will continue to outperform over next 6-8 months: Nilesh Jain
Domestic equity markets opened in the red on Monday amid mixed global cues. The headline S&P BSE Sensex tumbled 63 points to quote at 52,913 level
-
RIL Q1 results: Net profit falls 7.25% YoY to Rs 12273 crore
The fall in net profit is attributable to a rise in total expenses which came at Rs 1,31,284 crore in Q1FY21
-
Stock gains are like ketchup, come in spurts: Motilal Oswal
Giving an example, Susmit Patodia, Associate Director, Fund Manager, Motilal Oswal, pointed out diversion in valuations of midcap & largecap IT stocks
-
Should you invest in RIL? Here's what foreign brokerages say
RIL’s AGM, concluded with a clarion call towards accelerated adoption of renewables and commitment towards becoming net carbon-neutral by 2035
-
Trading ideas: Stock recommendations for next week
With regards to Nifty Bank, the level of 33,900 acted as a support during the week. Now at this juncture, the index is on the verge of a breakout
-
Clean tech next hypergrowth opportunity for RIL: Brokerages
HSBC said RIL should benefit from the PLI schemes that the government is rolling out for PV manufacturing and advanced energy storage plants
-
Should you buy RIL shares post-AGM? See expert views
RIL also announced an ultra affordable smartphone jointly developed by RIL and Google which is to be launched in September
-
Overall market trend remains bullish: Devang Shah
"Markets have been quite volatile in the past few trading sessions, so what we are seeing is a sharp bounce from those corrections"
-
Maruti Suzuki sets up multi-speciality hospital; joins RIL, Vedanta in boosting healthcare
Spread over 7.5 acres, it is expected to serve over 3.75 lakh people residing at Sitapur and adjoining villages
-
Vaccination drive: India Inc seeks to import vaccines for staff inoculation
The Tata Group is reportedly looking to float a global tender to procure vaccines for its employees
